Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 28, 2021

Study Completion Date

June 7, 2021

Conditions
Bladder Cancer
Interventions
OTHER

Intervention

Patients randomized into the intervention group will follow the European Urologic Association (EAU) surveillance guidelines for cystoscopy follow-ups during bladder cancer surveillance.

OTHER

Control

Patients randomized into the control group will follow the American Urologic Association (AUA) surveillance guidelines using cystoscopy ever 3 months for the first two years, and then every 6 months for 2 years.

Trial Locations (1)

78229

The University of Texas Health Science Center, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT02298998 - Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study | Biotech Hunter | Biotech Hunter